All around the world, people are logging-on and calling in to learn more about IP issues via the World Wide Web. SLW is leading the way in utilizing technology to transmit knowledge in a quick and convenient manner. These interactive sessions are broken down to cover specific topic areas especially relevant to technologies that originate in India. The sessions allow enrollees to take back-to-back courses to further increase their knowledge. As an added bonus, SLW web / telephone seminars are offered complimentary.

The current seminar series, Strategies for Indian R&D, will begin on May 28, 2007.

Register now for SLWK's new web / telephone seminar series - Strategies for Indian R&D.

Tuesday May 29, 2007 (90 min)
8:00AM-9:30AM (CST)
6:30PM-8:00PM (Indian Time)
Claiming Chemical and Pharmaceutical Inventions. Gary Speier (45 min.)
Willful Infringement and Opinions of Counsel. Suneel Arora (45 min.)

Monday July 30, 2007 (90 min)
8:00AM-9:30AM (CST)
6:30PM-8:00PM (Indian Time)
Exculpatory Opinions Under The Hatch-Waxman Act. Gary Speier (40 min.)
Contributory Infringement, and Inducement to Infringe. Ben Armitage (10 min.)
Non-Obviousness after KSR v. Teleflex, Ted McCullough (40 min.)

Monday September 24, 2007 (90 min)
8:00AM-9:30AM (CST)
6:30PM-8:00PM (Indian Time)
Review of seminal Hatch-Waxman Decisions. Ted McCullough (45 min.)
Patentable Subject Matter and 35 U.S.C. 101. John Fischer (45 min.)

Monday November 26, 2007 (90 min)
7:00AM-8:30AM (CST)
6:30PM-8:00PM (Indian Time)
Process Claims (patentability and infringement issues). Ben Armitage (45 min.)
Claiming Inventions in Software. Randy Canis (45 min.)

Monday February 4, 2008 (90 min)
7:00AM-8:30AM (CST)
6:30PM-8:00PM (Indian Time)
Entering U.S. National Phase via PCT. Mike Haukaas (35 min.)
Meeting the Best Mode Requirement. Karen Himmel (15 min.)
Drafting a Software Patent Specification and Avoiding circumvention. Randy Canis (40 min.)

Claiming Chemical and Pharmaceutical Inventions. Gary Speier (45 min.)
Claiming inventions in the chemical and pharmaceuticals arts warrants a clear understanding as to the options available to the savvy practitioner. This presentation will review the basic types of chemical claims: compound, product-by-process, method of use, composition, and process. Pitfalls inherent with some of these types of claims will be addressed and include a lack of written description requirement and inherency (anticipation). Additional types of claims that have been popular in the US will be addressed and include claims directed toward metabolites, pro-drugs and reach-through claims. The speaker will offer guidelines on how to attack the validity of improperly drafted US chemical claims, as well as advice on drafting chemical claims to withstand an attack of validity.

Willful Infringement and Opinions of Counsel. Suneel Arora (45 min.)
Have you become aware of a pesky problem U.S. patent that may affect your ability to market your product in the U.S.? What should you do? Should you seek a legal opinion-of-counsel from your U.S. patent attorney? This presentation discusses the significance of freedom-to-operate opinions, willful infringement, notice and the duty of due care, non-infringement opinions, invalidity and unenforceability opinions, how such opinions should be constructed, and how they should be treated to avoid a finding of willful patent infringement.

Exculpatory Opinions Under The Hatch-Waxman Act. Gary Speier (40 min.)
The Hatch-Waxman Act has affected product development, Orange Book listing strategies, market exclusivities and paragraph IV challenges. Current Hatch-Waxman litigation is replete with new controversies, all having substantial impact on the pharmaceutical patent endgame. Learn the strategies that generic pharmaceutical companies employ to successfully file abbreviated new drug applications (ANDA), to enter the US market.

Contributory Infringement, and Inducement to Infringe. Ben Armitage (10 min.)

Non-Obviousness after KSR v. Teleflex, Ted McCullough (40 min.)

Review of seminal Hatch-Waxman Decisions. Ted McCullough (45 min.)

Patentable Subject Matter and 35 U.S.C. 101. John Fischer (45 min.)
The scope of patentable subject matter under 35 U.S.C. 101 continues to be debated in the courts. In particular, business method claims, computer-readable medium claims, and signal claims are receiving increased scrutiny under 101. This presentation briefly reviews the 101 jurisprudence, outlines the recent BPAI decision In Re Lundgren, and provides some guidance on how to respond when faced with 101 rejections. The presentation also includes several case studies demonstrating response strategies and outcomes.

Process Claims (patentability and infringement issues). Ben Armitage (45 min).

Claiming Inventions in Software. Randy Canis (45 min.)

Entering U.S. National Phase via PCT. Mike Haukaas (35 min.)

Meeting the Best Mode Requirement. Karen Himmel (15 min.)
For an invention to be patentable, the application specification must set forth the "best mode" contemplated by the inventor of carrying out the invention. This requirement is recited in 35 U.S.C. 112 and has been addressed in the case law. This seminar will highlight portions of the statute and case law regarding how to satisfy the best mode requirement, certain actions to avoid, and the legal standards employed by the USPTO and Federal Circuit in best mode analysis.

Drafting a Software Patent Specification and Avoiding circumvention. Randy Canis (40 min.)